Pure Global

BD Gram-negative Drug Susceptibility Panel - Folate Pathway Antagonist - Taiwan Registration 5fd572b0d24b4c1fc4ed6beb59cf1f74

Access comprehensive regulatory information for BD Gram-negative Drug Susceptibility Panel - Folate Pathway Antagonist in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5fd572b0d24b4c1fc4ed6beb59cf1f74 and manufactured by BECTON DICKINSON AND COMPANY. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5fd572b0d24b4c1fc4ed6beb59cf1f74
Registration Details
Taiwan FDA Registration: 5fd572b0d24b4c1fc4ed6beb59cf1f74
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BD Gram-negative Drug Susceptibility Panel - Folate Pathway Antagonist
TW: BD ้ฉ่˜ญๆฐ้™ฐๆ€ง่Œ่—ฅ็‰ฉๆ•ๆ„Ÿๆ€ง่ฉฆๅŠ‘็ต„-่‘‰้…ธ่ทฏๅพ‘ๆ‹ฎๆŠ—ๅŠ‘
Risk Class 2

Registration Details

5fd572b0d24b4c1fc4ed6beb59cf1f74

DHA05603751309

Company Information

Product Details

This product contains selective antimicrobials (listed in Table 1 of the instructions) for drug tolerance testing against most gram-negative aerobic and facultative anaerobes, and must be used with the Phoenix Automated Microbiological System instrument.

C Immunology and microbiology

C.1645 Automatic Antibiotic Sensitivity Test System for Short Incubation Period

Input;; QMS/QSD

Dates and Status

Nov 12, 2024

Nov 12, 2029